Urivoid 25 Mg
Information About Urivoid 25 Mg
About Urivoid 25 Mg
Medicine Brand Urivoid 25 mg is manufactured by Cipla Limited and mainly contents the generic drug Bethanechol.
Pakaging
10 Tablet
Active Ingredients For Urivoid 25 Mg
Bethanechol 25 mg
Diseases List For Which Urivoid 25 Mg Is Prescribed
This Drug Is Prescribed For Acute postoperative and postpartum nonobstructive functional urinary retention and for neurogenic atony of the urinary bladder with retention
Other Significations For Urivoid 25 Mg
This Medication Antispasmodics are anticholinergic agents that inhibit involuntary detrusor contractionsThere are two types of nicotinic receptors muscle type mainly in skeletal neuromuscular junction or neuronal type in autonomic ganglia sensory nerve terminals and other regions in the central nervous system There are three types of muscarinic receptors M1 M2 M3 M1 receptors neural mainly located in the central nervous system M2 receptors cardiac in atria and conducting tissue and M3 receptors glandular in exocrine glands smooth muscle and vascular endotheliumUrinary antispasmodics can be nonselective anticholinergic agents ones that can bind to all the receptors of the cholinergic system nicotinic and muscarinic receptors or they can selectively block M3 muscarinic receptors Selective M3 receptor blockers cause less drowsiness compared to the nonselective anticholinergic drugs but they can cause more constipation dry mouth and blurred vision
Precautions To Be Taken Before Urivoid 25 Mg
This medication may interfere with certain laboratory tests including urine ketone test possibly causing false test results
Major Conditions And Care
Pregnancy And Urivoid 25 Mg
Can We Take Urivoid 25 Mg During Pregnancy?
Pregnancy Class : D There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans but potential benefits may warrant use of the drug in pregnant women despite potential risks
Lactation And Urivoid 25 Mg
Can We Use Urivoid 25 Mg During Lactation
Lactation Class L5 Studies in breastfeeding mothers have demonstrated that there is significant and documented risk to the infant based on human experience or it is a medication that has a high risk of causing significant damage to an infant The risk of using the drug in breastfeeding women clearly outweighs any possible benefit from breastfeeding The drug is contraindicated in women who are breastfeeding an infant
Side Effects Of Urivoid 25 Mg
Nausea stomach upset skin rash acute toxicity